Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (1) Daniel, Peter Prof. Dr. (1) Henssen, Anton Prof. Dr. med. (1) Höpken, Uta Elisabeth PD Dr. (1) Kammertöns, Thomas Dr. (1) Kieback, Elisa Dr. (1) Kopp, Joachim Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (2) Na, Il-Kang Dr. (1) Obermayer-Wasserscheid, Benedikt Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Schlag, Peter M. Prof. Dr. (1) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (3) Willimsky, Gerald Dr. (3) (-) Blankenstein, Thomas Prof. Dr. (12) Bioinformatics and Omics Data Science (1) Biologie maligner Lymphome (12) Entwicklung Mechanismus-basierter Krebstherapien (1) Immundysregulationen in der Onkologie (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (2) (-) Molekulare Immunologie und Gentherapie (12) Systembiologie von Gen-regulatorischen Elementen (2) Translational Bioinformatics (1) Translationale Onkologie solider Tumore (1) Translationale Tumorimmunologie (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) (-) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (11) 2014 (3) (-) 2015 (3) 2016 (4) 2017 (6) 2018 (5) 2019 (6) (-) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 12 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Molekulare Immunologie und Gentherapie 200820152021 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Juni 2021 / Thyroid Thyrotropin receptor-specific lymphocytes in adenovirus-TSHR-immunized native and human leukocyte antigen-DR3-transgenic mice and in Graves' disease patient blood H. Degen I. Gavvovidis T. Blankenstein K. Uhland M. Ungerer 15. Juni 2021 / Int J Cancer Long-term in vitro expansion ensures increased yield of central memory T cells as perspective for manufacturing challenges S. Herda A. Heimann B. Obermayer E. Ciraolo S. Althoff J. Ruß C. Grunert A. Busse L. Bullinger A. Pezzutto T. Blankenstein D. Beule I.K. Na 02. März 2021 / Cancers CD28 co-stimulus achieves superior CAR T cell effector function against solid tumors than 4-1BB co-stimulus A. Textor L. Grunewald K. Anders A. Klaus S. Schwiebert A. Winkler M. Stecklum J. Rolff A.G. Henssen U.E. Höpken A. Eggert J.H. Schulte M.C. Jensen T. Blankenstein A. Künkele 20. April 2021 / eLife In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo G. Willimsky C. Beier L. Immisch G. Papafotiou V. Scheuplein-Schlosser A. Goede H.G. Holzhütter T. Blankenstein P.M. Kloetzel 01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber 01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein 15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann 08. September 2008 / Canc Lett Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient mice D.V. Kuprash Z. Qin D. Ito S.I. Grivennikov K. Abe L.N. Drutskaya T. Blankenstein S.A. Nedospasov 11. November 2008 / Proc Natl Acad Sci U S A Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas A. Kruschinski A. Moosmann I. Poschke H. Norell M. Chmielewski B. Seliger R. Kiessling T. Blankenstein H. Abken J. Charo 15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Juni 2021 / Thyroid Thyrotropin receptor-specific lymphocytes in adenovirus-TSHR-immunized native and human leukocyte antigen-DR3-transgenic mice and in Graves' disease patient blood H. Degen I. Gavvovidis T. Blankenstein K. Uhland M. Ungerer
15. Juni 2021 / Int J Cancer Long-term in vitro expansion ensures increased yield of central memory T cells as perspective for manufacturing challenges S. Herda A. Heimann B. Obermayer E. Ciraolo S. Althoff J. Ruß C. Grunert A. Busse L. Bullinger A. Pezzutto T. Blankenstein D. Beule I.K. Na
02. März 2021 / Cancers CD28 co-stimulus achieves superior CAR T cell effector function against solid tumors than 4-1BB co-stimulus A. Textor L. Grunewald K. Anders A. Klaus S. Schwiebert A. Winkler M. Stecklum J. Rolff A.G. Henssen U.E. Höpken A. Eggert J.H. Schulte M.C. Jensen T. Blankenstein A. Künkele
20. April 2021 / eLife In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo G. Willimsky C. Beier L. Immisch G. Papafotiou V. Scheuplein-Schlosser A. Goede H.G. Holzhütter T. Blankenstein P.M. Kloetzel
01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann
08. September 2008 / Canc Lett Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient mice D.V. Kuprash Z. Qin D. Ito S.I. Grivennikov K. Abe L.N. Drutskaya T. Blankenstein S.A. Nedospasov
11. November 2008 / Proc Natl Acad Sci U S A Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas A. Kruschinski A. Moosmann I. Poschke H. Norell M. Chmielewski B. Seliger R. Kiessling T. Blankenstein H. Abken J. Charo
15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert